These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 34419629)

  • 1. The rise and rise of protein degradation: Opportunities and challenges ahead.
    Hughes SJ; Testa A; Thompson N; Churcher I
    Drug Discov Today; 2021 Dec; 26(12):2889-2897. PubMed ID: 34419629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced degradation of protein kinases by bifunctional small molecules: a next-generation strategy.
    Groppe JC
    Expert Opin Drug Discov; 2019 Dec; 14(12):1237-1253. PubMed ID: 31513432
    [No Abstract]   [Full Text] [Related]  

  • 3. Frontiers in PROTACs.
    Hughes GR; Dudey AP; Hemmings AM; Chantry A
    Drug Discov Today; 2021 Oct; 26(10):2377-2383. PubMed ID: 33872800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for designing proteolysis targeting chimaeras (PROTACs).
    He S; Dong G; Cheng J; Wu Y; Sheng C
    Med Res Rev; 2022 May; 42(3):1280-1342. PubMed ID: 35001407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design.
    Chen Y; Liu F; Pal S; Hu Q
    Chem Soc Rev; 2024 Sep; 53(19):9582-9608. PubMed ID: 39171633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
    Gu S; Cui D; Chen X; Xiong X; Zhao Y
    Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breaking Bad Proteins-Discovery Approaches and the Road to Clinic for Degraders.
    Bouvier C; Lawrence R; Cavallo F; Xolalpa W; Jordan A; Hjerpe R; Rodriguez MS
    Cells; 2024 Mar; 13(7):. PubMed ID: 38607017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic approaches advancing targeted protein degradation.
    Sathe G; Sapkota GP
    Trends Pharmacol Sci; 2023 Nov; 44(11):786-801. PubMed ID: 37778939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of IAP-recruiting BCL-X
    Zhang X; He Y; Zhang P; Budamagunta V; Lv D; Thummuri D; Yang Y; Pei J; Yuan Y; Zhou D; Zheng G
    Eur J Med Chem; 2020 Aug; 199():112397. PubMed ID: 32388279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?
    Kuemper S; Cairns AG; Birchall K; Yao Z; Large JM
    Front Mol Neurosci; 2024; 17():1370509. PubMed ID: 38685916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROTACs- a game-changing technology.
    Konstantinidou M; Li J; Zhang B; Wang Z; Shaabani S; Ter Brake F; Essa K; Dömling A
    Expert Opin Drug Discov; 2019 Dec; 14(12):1255-1268. PubMed ID: 31538491
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted protein degradation: mechanisms, strategies and application.
    Zhao L; Zhao J; Zhong K; Tong A; Jia D
    Signal Transduct Target Ther; 2022 Apr; 7(1):113. PubMed ID: 35379777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted protein degradation by PROTACs.
    Neklesa TK; Winkler JD; Crews CM
    Pharmacol Ther; 2017 Jun; 174():138-144. PubMed ID: 28223226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring and deciphering protein degradation pathways inside cells.
    Daniels DL; Riching KM; Urh M
    Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery.
    Guedeney N; Cornu M; Schwalen F; Kieffer C; Voisin-Chiret AS
    Drug Discov Today; 2023 Jan; 28(1):103395. PubMed ID: 36228895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rise of covalent proteolysis targeting chimeras.
    Gabizon R; London N
    Curr Opin Chem Biol; 2021 Jun; 62():24-33. PubMed ID: 33549806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of Protein Knockdown Technology as Emerging Drug Discovery Strategy].
    Ohoka N
    Yakugaku Zasshi; 2018; 138(9):1135-1143. PubMed ID: 30175757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PROTACs technology for targeting non-oncoproteins: Advances and perspectives.
    Wang C; Zhang Y; Xing D; Zhang R
    Bioorg Chem; 2021 Sep; 114():105109. PubMed ID: 34175722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
    Lin J; Jin J; Shen Y; Zhang L; Gong G; Bian H; Chen H; Nagle DG; Wu Y; Zhang W; Luan X
    Theranostics; 2021; 11(17):8337-8349. PubMed ID: 34373745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel approaches to targeted protein degradation technologies in drug discovery.
    Xue Y; Bolinger AA; Zhou J
    Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.